HI

Hepatology International

Hepatology International is a peer-reviewed journal dedicated to research and patient care issues in hepatology. It focuses on contemporary clinical and basic science related issues in adult and pediatric hepatobiliary and allied sciences, and publishes original research articles, editorials, reviews, and consensus guidelines for diagnosis and treatment of liver diseases. The journal emphasizes new and emerging technologies, innovations, and future trends in liver and biliary disorders.

Looking to publish in Hepatology International? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Gastroenterology & Hepatology
Impact Factor 6.1
Quartile Q1
Open Access Type Hybrid
ISSN 1936-0533
eISSN 1936-0541
Invitation Only Yes
Cost Range Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Hepatology International is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Original Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Original Articles. Abstract must be structured and limited to 250 words. Abstract must be structured.
Manuscript Manuscript text must not exceed 4000 words including references. Manuscript must be organized into Introduction, Materials and Methods, Results, and Discussion. Manuscript must include 10 keywords, a concept diagram or graphical abstract immediately after the abstract, and declarations just before the reference section.
References Reference list must not exceed 30 references. References must follow the U.S. National Library of Medicine style as in Index Medicus. References must be numbered in order of first appearance in the text, with repeated citations using the original number.
Figures & Tables Original Articles may include up to 6 tables, flow diagrams, colored figures, text boxes, or other illustrations. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. The graphical abstract must be a single-panel high-resolution image of at least 300 dpi, preferably in .tif or .jpg format, using RGB color and Arial 12–16 pt font.
Reformat to Hepatology International using Livewrite Premium

Review Article

Cover Letter Submission must be approved by all co-authors and by the responsible authorities at the institute where the work was carried out.
Abstract An abstract is required for Review Articles. The abstract must be limited to 250 words. The abstract must be unstructured.
Manuscript The text must not exceed 5000 words including references. The main text must be organized into an introductory section followed by Discussion, Conclusion, and Perspective. Review Articles must include 10 keywords and declarations just before the reference section.
References The reference list must not exceed 100 references. References must follow the U.S. National Library of Medicine style as in Index Medicus. References must be numbered in order of first appearance in the text and reused with the same number on subsequent citation.
Figures & Tables Review Articles must include at least 4 colored figures and at least 4 tables, with no more than 8 total tables, flow diagrams, colored figures, text boxes, or other illustrations. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Each table and figure must be numbered in Arabic numerals and cited in the text in consecutive numerical order.
Reformat to Hepatology International using Livewrite Premium

Mini Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be structured. Abstract must not exceed 150 words. Abstract must be structured.
Manuscript Text must not exceed 2500 words excluding references. Declarations must be included just before the reference section. Mini Reviews must include 10 keywords.
References Reference list must not exceed 30 references. References must follow the U.S. National Library of Medicine style used in Index Medicus. References must be numbered in order of first appearance in the text, and repeated citations must use the original reference number.
Figures & Tables Mini Reviews may include up to 4 tables, flow diagrams, colored figures, text boxes, or other illustrations, and should include at least 2 colored figures and at least 2 tables or algorithms. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Each table and figure must be numbered in Arabic numerals, cited in consecutive numerical order, and accompanied by a caption, with figure captions included in the manuscript text file rather than in the figure file.
Reformat to Hepatology International using Livewrite Premium

Consensus

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Consensus manuscripts must not exceed 2000 words. Manuscripts should include funding information and, as appropriate, financial or non-financial interests, ethics committee approval, informed consent, and animal welfare statements.
References Consensus manuscripts must not include more than 9 references. References must follow the U.S. National Library of Medicine style as in Index Medicus. References must be numbered in order of first appearance in the text and reused with the same number for subsequent citations.
Figures & Tables Figures should be submitted within the body of the text, with large figures uploaded separately only if file size causes problems. Each table and figure must be numbered with Arabic numerals and cited in consecutive numerical order, and each figure must have a concise caption included in the manuscript text file.
Reformat to Hepatology International using Livewrite Premium

Letter To Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Text must not exceed 500 words excluding references. Keywords must not be included, and one figure must be included.
References Reference list must not exceed 5 references. References must follow the U.S. National Library of Medicine style as in Index Medicus. References must be numbered in order of first appearance in the text, and repeated citations must use the original reference number.
Figures & Tables Submission must include one figure. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Each figure must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by a concise caption included in the manuscript text file rather than in the figure file.
Reformat to Hepatology International using Livewrite Premium

Recent Publications

Epidemiology of primary sclerosing cholangitis in general and IBD populations: a systematic review and meta-analysis

Glenn Jun Kit Ho, Asvin Selvakumar, Lucas Yang Yuxu Yeo, Mako Eguchi, Ryan Yanzhe Lim, Benedix Kuan Loon Sim, Daniel Tung, Apoorva N Sasikumar, Shirley Huey Shin Bong, Ethan Kai Jun Tham, Jia Hao Law, Eunice Xiang-Xuan Tan, Brian J. Wentworth, Won-Mook Choi, Aparna Goel, David N. Assis, Benjamin Nah, Vincent L. Chen

10.1007/s12072-026-11127-y
View Publication

Neutrophil extracellular traps drive cholangiocyte injury via ZNF709–TP53–MDM2 pathway in primary biliary cholangitis

Mingxin Su, Zhenfeng Tian, Miao Yu, Enlai Huang, Jinjian Liang, Bingrong Hu, Yinting Chen

10.1007/s12072-026-11128-x
View Publication

New oral anticoagulants and hepatocellular carcinoma among patients with HBV, HCV, and alcoholic liver diseases: a nationwide cohort study

Yu-Wen Su, Yu-Hsuan Pai, Yao-Min Hung, Fuu-Jen Tsai, Renin Chang, Sung-Shuo Kao

10.1007/s12072-026-11117-0
View Publication

Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab–bevacizumab in hepatocellular carcinoma

Akimitsu Meno, Masatsugu Ohara, Goki Suda, Takuya Sho, Osamu Maehara, Naohiro Yasuura, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, Shunsuke Ohnishi, Takashi Kitagataya, Naoki Kawagishi, Masato Nakai, Mitsuteru Natsuizaka, Koji Ogawa, Naoya Sakamoto

10.1007/s12072-026-11124-1
View Publication

Efficacy of tirzepatide versus SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study

Ibrahim Khalil, Pallab Sarker, Nabila Nur, Md. Imran Hossain, Aizaz Anwar Khalid, Sajjad Ghanim Al-Badri, Mst. Mahmuda Akter, Manisha Das, Mohd Turzo Rahman

10.1007/s12072-026-11122-3
View Publication

Frequently asked questions

How long does it take to publish?

Articles are published online after receipt of the corrected proofs.

Reformat to Hepatology International using Livewrite Premium

Is a cover letter required?

A submission letter is used when suggesting reviewers and when disclosing unpublished material included in the manuscript.

Reformat to Hepatology International using Livewrite Premium

What are the publication costs?

Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR, subject to VAT or local taxes where applicable. Subscription publishing has no APC charges.

Reformat to Hepatology International using Livewrite Premium

Research Topics

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Hepatitis C virus research Hepatitis B Virus Studies Hepatocellular Carcinoma Treatment and Prognosis Organ Transplantation Techniques and Outcomes Hepatitis Viruses Studies and Epidemiology Liver Diseases and Immunity Liver physiology and pathology Cholangiocarcinoma and Gallbladder Cancer Studies Alcohol Consumption and Health Effects Drug-Induced Hepatotoxicity and Protection Diabetes, Cardiovascular Risks, and Lipoproteins Cancer Immunotherapy and Biomarkers HIV/AIDS drug development and treatment Gallbladder and Bile Duct Disorders Diet, Metabolism, and Disease Pediatric Hepatobiliary Diseases and Treatments Ferroptosis and cancer prognosis Radiomics and Machine Learning in Medical Imaging Drug Transport and Resistance Mechanisms Nutrition and Health in Aging Inflammatory Biomarkers in Disease Prognosis Cancer, Hypoxia, and Metabolism Cancer Mechanisms and Therapy

Related Journals

EJ
Egyptian Journal of Bronchology Springer Science+Business Media
IJ
International Journal of Clinical Oncology Springer Science+Business Media
CE
Current Environmental Health Reports Springer Science+Business Media
IA
Internal and Emergency Medicine Springer Science+Business Media
˜œ
˜The œLancet. Gastroenterology & hepatology Elsevier BV
TA
Therapeutic Advances in Gastroenterology SAGE Publishing